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Abstract: Hypericin (HYP)-mediated photodynamic therapy (PDT) is a new alternative treatment strategy for colon cancer inducing
various cell-death pathways. Apoptotic cell death is the desired cellular fate in cancer cells. Therefore, we investigated the apoptotic
pathways by determining apoptosis-related proteins (survivin, caspase-3, caspase-9, Bcl-2, and Bax) at the mRNA level using real-time
polymerase chain reaction (qPCR), and the percentage of survivin was determined by survivin ELISA in HT-29 and Caco-2 colon
cancer cell lines. The downregulation of survivin was significant 16 h after PDT for both cells, while caspase-3 upregulation was apparent
24 h after PDT. Caspase-9 and caspase-3 upregulations were parallel to each other. There was no Bcl-2 expression in HT-29 cells, but we
observed downregulation in Bcl-2 expression in Caco-2 cells after HYP photoactivation. The Bax expression downregulated significantly
after 24 h incubation in HT-29 cells, while it was upregulated after 16 h incubation in Caco-2 cells. The present study provides evidence
that HYP-induced alterations in apoptosis-related protein expression ended in different responses in HT-29 and Caco-2 colon cancer
cells, and these may be used in the treatment of chemotherapy-resistant cancer types.
Key words: Hypericin, PDT, survivin, apoptosis, HT-29 cells, Caco-2 cells

1. Introduction
Colorectal cancer is a prominent death factor and the
third most common cancer worldwide (Jemal et al., 2011).
Early diagnosis and efficient treatment are significant for
patient survival. Surgical resection is the main curative
option for patients with metastatic type of colon cancer,
but survival rates of patients with stage IV disease are
fairly low after surgical resection (Fong et al., 1997; Gaston
and Giacomantonio, 2014). Since treatment of severe
cancer types with conventional methods is not possible,
new strategies become important for diagnostic methods
and patient survival (Fournier and Gordon, 2000).
Photodynamic therapy (PDT) is one good candidate for
new treatment strategies. PDT involves photosensitizer
(PS), irradiation with a wavelength appropriate for PS,
and molecular oxygen (Agostinis et al., 2011). Molecular
oxygen is converted into singlet oxygen (1O2) and other
cytotoxic oxygen species, such as hydroxyl radical (OH*)
and superoxide anion radical (O2–). The type and dose
of PS, the light source, and its intensity and cell type are
important factors for determining the success of PDT.
Following treatment with PDT, cell destiny leads to repair
* Correspondence: cagatayk@hacettepe.edu.tr

of the damage, autophagy or apoptosis, and necrosis
(Krammer and Verwanger, 2012).
Hypericin (HYP) is a natural PS extracted from
Hypericum perforatum. Due to its low cytotoxicity and
selective antitumor features, HYP has been used for the
treatment of tumor tissues (Agostinis et al., 2002; Kiesslich
et al., 2006; Barathan et al., 2013). It has been suggested
that after treatment of HYP-mediated PDT, cells move
towards cellular pathways according to the concentration
of treated HYP. Low-dose concentrations of HYP induce
growth stimulation via the p38 or JNK survival pathways.
Unlike the effect of a low dose, a high dose of HYP leads
to activation of stress-response pathways that trigger
apoptosis or autophagic cell death. If the damage is too
severe, the cell dies necrotically (Krammer and Verwanger,
2012).
In order to identify the correct HYP dose and
irradiation time, appropriate marker genes should be
monitored during the treatment process. Survivin is an
anti-apoptotic protein that is a member of the inhibitor
of apoptosis proteins (IAP) family (Deveraux and Reed,
1999). It is selectively expressed in tumor versus normal
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tissues (Jiang et al., 2001). This protein plays an important
role in the regulation of cell division and suppression of
apoptosis and is also involved in cellular processes such as
cellular stress response, chemoresistance, and angiogenesis
(Altieri, 2006). Survivin inhibits caspase proteins such as
caspase-3, caspase-7, and caspase-9. In this way, apoptosis
is prevented and tumor cell survival increases (Chu et al.,
2010; Hernandez et al., 2011). Increased expression of the
survivin protein is associated with tumor resistance to
chemotherapeutic drug treatment, poor prognosis, and
decreased patient survival (Ferrario et al., 2007). Therefore,
survivin protein is a good candidate for monitoring tumor
progression.
Caspase-3 is an executioner caspase that catalyzes
the cleavage of many cellular proteins, and this cleavage
is followed by apoptosis-related cellular alterations.
Caspase-3 is a fundamental protein frequently used to
investigate apoptotic pathways (Devarajan et al., 2002).
During apoptosis, cytochrome-c (cyt-c) releases from
mitochondria into the cytosol and induces the caspase
activation pathway starting with procaspase-9 activation.
This leads to activation of procaspase-3 and cell death
(Hostanska et al., 2003). It is commonly accepted that Bcl2 and Bcl-XL, which are members of the BCL-2 family,
inhibit the release of cyt-c, while proapoptotic members
such as Bid, Bax, and Bad facilitate the release of cyt-c.
Therefore, decreasing the expression of Bcl-2 is a way of
increasing the activity and sensitivity of PDT in particular
cell lines (Fadeel et al., 1999).
In this study, we aimed to evaluate the apoptotic cell
death mechanisms in HT-29 and Caco-2 cells after HYPmediated PDT. For this purpose, survivin, caspase-3,
caspase-9, Bcl-2, and Bax gene expressions and the levels
of survivin in cell lysates were measured.
2. Materials and methods
2.1. Cell culture conditions and PDT procedure
HT-29 (passage numbers 7–10) and Caco-2 (passage
numbers 13–20) cells were obtained from and the Foot
and Mouth Disease Institute (HÜKÜK), Ankara, Turkey.
The cells were maintained in Dulbecco’s Modified Eagle
medium (DMEM) (HyClone Laboratories, Inc., Logan,
UT, USA) supplemented with 10% fetal bovine serum
(PAA Laboratories, Linz, Austria) at 37 °C and 5% CO2 in
a humidified incubator. The cell lines were routinely tested
for mycoplasma and other contamination throughout the
experiment and only used if they were contamination-free.
HYP HPLC grade (AppliChem, Germany) was prepared
as a stock solution in dimethyl sulfoxide (DMSO) (final
concentration, <0.1%). HYP concentrations were chosen
according to results of a 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) cytotoxicity test (Kılıç
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Süloğlu et al., 2015). The cells were incubated with 0.04,
0.08, and 0.15 µM HYP concentrations in dark conditions
for 24 h. Prior to irradiation, the medium containing HYP
was replaced with fresh HYP-free DMEM. A dark control
group at 0.15 µM HYP incubation without irradiation was
also included. The irradiation device consisted of twelve
L18W/830 fluorescent tubes (Osram, Berlin, Germany)
with maximum emission in the range 530–620 nm and
included 8 fans to prevent overheating. The light dose
was measured with TES 1335 luxmeter (Rotronic, Taipei,
Taiwan). HYP was activated by light at a total dose of 4 J/
cm2. The groups are control group (no HYP treatment but
photoactivated), DMSO group (DMSO treatment only and
photoactivated), and HYP treatment groups (0.04, 0.08,
and 0.15 µM HYP treatment and photoactivated). As the
control group and DMSO group had no differences in any
measured parameters, DMSO group data were not shown.
Analysis was performed 16 h and 24 h after irradiation,
and the experiments were performed in triplicate.
2.2. Total protein assay
HT-29 and Caco-2 cells were seeded at a density of 75 ×
104 viable cells per 75 cm2 culture flask for control and HYP
treatment groups. After HYP activation, cells were washed
with ice-cold phosphate-buffered saline (PBS), scraped off,
and solubilized in ice-cold RIPA buffer containing 25 mM
Tris-HCl pH 7.6, 150 nM NaCl, 1% NP-40, 1% sodium
deoxycholate, and 0.1% SDS (Pierce Biotechnology 89901,
Rockford, IL, USA) with protease inhibitor cocktail (Roche
11873580001, Mannheim, Germany). Cell lysates were
centrifuged at 13,000 rpm for 30 min, and supernatant was
separated and stored at –80 °C. Protein concentrations of
cell lysates were measured at 562 nm with a microplate
spectrophotometer (μQuant, Bio-Tek Instruments, Inc.,
Winooski, VT, USA) and bicinchoninic acid protein
analysis kit (Pierce Biotechnology 23227, Rockford, IL,
USA).
2.3. Survivin protein measurement
Survivin levels in cell lysates were quantified using a
sandwich enzyme-linked immunosorbent assay kit
(ELISA) according to the manufacturer’s guidelines
(Cell Signaling Technology, Danvers, MA, USA). Equal
amounts of protein samples were loaded into survivinantibody–coated wells, and absorbances were read at 450
nm with a microplate spectrophotometer (μQuant, BioTek Instruments, Inc., Winooski, VT, USA). Data was
expressed as percentage of survivin.
2.4. RNA isolation and cDNA synthesis
Total RNA was isolated from HT-29 and Caco-2 cells using
an RNeasy Mini kit (Qiagen, Valencia, CA, USA). Firststrand cDNA was synthesized from 0.5 µg of RNA with the
Superscript III First-Strand Synthesis system (Invitrogen,
Carlsbad, CA, USA) using 0.5 µg of oligo-dT. Real time-
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PCR experiments were performed on the ABI 7500 Fast
Real Time-PCR system and with a Quantifast SYBR Green
PCR kit. PCR conditions were as follows: PCR initial
heat activation at 95 °C for 5 min followed by 40 cycles of
denaturation at 95 °C for 10 s and combined annealing–
extension at 60 °C for 30 s. All reactions were performed in
triplicate and repeated at least 2 times. Cyclophilin A gene
(PPIA) was used as an internal reference to normalize the
target transcripts using the 2−ΔΔCT method. Real-time PCR
primers designed for PPIA, survivin, Bax, and caspase-3
are listed in the Table. The other primers for caspase-9
(Hs CAS9 1 SG QuantiTect Primer assay) and Bcl-2 (Hs
BCL2 1 SG QuantiTect Primer assay) were obtained from
Qiagen (Valencia, CA, USA). Data were given as the
relative expression ratio (gene expression/reference gene
expression).
2.5. Statistical analysis
Statistical analysis was performed using SPSS 22 for
Windows. Data were expressed as mean ± standard error
(SE), and statistical significance was assigned at the P
≤ 0.05 level. The homogeneity of variance and normal
distribution between groups were evaluated by general
linear model procedure and Kolmogorov–Smirnov
nonparametric test. Parameters were analyzed by oneway ANOVA. To identify the sources of significant main
effect, post hoc comparisons (Tukey) were used (Sokal et
al., 1995).
3. Results and discussion
There have been limited reports to provide a relationship
between gene expressions of apoptosis-associated proteins
such as survivin, Bax, Bcl-2, caspase-3, and caspase-9 after
response to HYP-mediated PDT in Caco-2 cells. The aim of
this study was to evaluate these proteins in order to predict
HYP resistance of colon cancer cells and to determine
modifications in their mRNA expressions. There were
several reports about HYP photoactivation and results in
HT-29 cells, but in the current study we investigated this in
Caco-2 cells for the first time.

Based on the MTT cytotoxicity assay, we determined
the HYP concentrations of 0.04 µM, 0.08 µM, and 0.15
µM. These concentrations caused 20%–42% inhibition
of metabolic activity and induced a significant increase
in apoptotic index in HT-29 and Caco-2 cells. The
percentages of inhibition were 82.54 ± 1.57 (0.04 µM
HYP), 68.85 ± 4.88 (0.08 µM HYP), and 57.09 ± 5.63 (0.15
µM HYP) after 16 h incubation and 81.98 ± 2.35 (0.04 µM
HYP), 66.64 ± 3.96 (0.08 µM HYP), and 55.51 ± 1.67 (0.15
µM HYP) after 24 h incubation in HT-29 cells. For Caco-2
cells the percentages of inhibition were 84.57 ± 4.02 (0.04
µM HYP), 71.61 ± 5.30 (0.08 µM HYP), and 61.50 ± 3.43
(0.15 µM HYP) after 16 h incubation and 87.66 ± 3.95
(0.04 µM HYP), 74.83 ± 1.45 (0.08 µM HYP), and 65.01 ±
1.27 (0.15 µM HYP) after 24 h incubation (Kılıç Süloğlu et
al., 2015). In this study, further analysis was performed in
order to explain apoptotic mechanisms and related protein
alterations due to HYP photoactivation. We have studied
the effect of HYP-mediated PDT on survivin, caspase-3,
caspase-9, Bcl-2, and Bax gene expressions and cellular
levels of survivin and total protein content.
The protein assay measures the protein content of
viable cells, which is an indirect measurement of cell
viability, and evaluates cell toxicity with supporting other
cytotoxicity assays (Fotakis and Timbrell, 2006). According
to Kılıç Süloğlu et al. (2015), 0.04, 0.08, and 0.15 µM HYP
induced cytotoxicity in HT-29 and Caco-2 cells. In this
study, the decrease in protein content depending on HYP
concentration was parallel to increased cytotoxicity. The
protein content decreased substantially in 0.04, 0.08, and
0.15 µM HYP groups of HT-29 cells 24 h after PDT (Figure
1A). In Caco-2 cells, the protein content also decreased in
HYP groups compared to the control group. In contrast
to HT-29 cells, the protein content increased after 24 h
incubation in Caco-2 cells except in the 0.15 µM HYP
group, which indicated higher cell number and lower
cytotoxicity in these groups (Figure 1B).
Survivin (BIRC5) is a member of the IAPs family that
is expressed in many different cancer cell types (Coumar

Table. Real-time primer sequences.
Gene

Real-time primer sequences

PPIA

Forward: 5’- GGTCCCAAAGACAGCAGAAA -3’
Reverse: 5’- GTCACCACCCTGACACATAAA -3’

Survivin

Forward: 5’- CCACCGCATCTCTACATTCA -3’
Reverse: 5’- CCAAGTCTGGCTCGTTCTC -3’

Bax

Forward: 5’- TTCTGACGGCAACTTCAACT -3’
Reverse: 5’- CAGCCCATGATGGTTCTGAT -3’

Caspase-3

Forward: 5’- CTCTGGAATATCCCTGGACAAC -3’
Reverse: 5’- ACATCTGTACCAGACCGAGA -3’
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HT-29 cells
Total protein (µg/mL)
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A
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#
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0

Control
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4500
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B

3500

#

3000
2500

#
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HT-29 cells, percentage of survivin in the 0.04, 0.08, and
0.15 µM HYP groups decreased significantly compared to
the control group for 16 h and 24 h incubation. In HT-29
cells, percentage of survivin in the 0.08 µM HYP group
diminished significantly compared to the control and 0.04
µM HYP group 16 h after PDT (Figure 2A). Similarly, for
24 h incubation, percentage of survivin in all dose groups
decreased compared to the control group. In Caco-2 cells,
percentage of survivin in the 0.08 and 0.15 µM HYP groups
decreased significantly compared to the control group at
both 16 h and 24 h incubation (Figure 2B). Additionally,
the 0.15 µM HYP group was significantly different from
the 0.04 µM HYP group 24 h after PDT.
In order to evaluate cell-death pathways, we performed
qPCR to investigate gene expressions of survivin, caspase-3,
caspase-9, Bcl-2, and Bax. According to the results, HYP
photoactivation induced a decrease in survivin expression
in HT-29 cells. The decrease was statistically significant in
0.08 and 0.15 µM HYP groups compared to the control
after 16 h and 24 h with the exception of upregulation
in 0.08 µM HYP after 24 h (Figure 3A). The decline in

1000
500

120
0.04 µM HYP 0.08 µM HYP 0.15 µM HYP

et al., 2013). Survivin contributes several processes related
to the regulation of mitosis, apoptosis, and cellular stress
response, but it cannot inhibit caspases directly (Mikešová
et al., 2013). Survivin prevents apoptosis by contributing
to the inhibition of caspase-3 and caspase-7. Survivin is
also expressed in transformed cell lines in a cell-cycle–
dependent manner in order to regulate the cell cycle in G2
and M phases (Suzuki et al., 2000). Previous studies by Kılıç
(2012) revealed that HYP-mediated PDT induced G2/M
arrest in the cell cycle of HT-29 and Caco-2 cells, which
might be related to fluctuation in survivin expression.
However, they did not investigate the alterations in
mRNA and protein levels of survivin expression after HYP
photoactivation.
In this study, alterations in percentage of survivin in
HT-29 and Caco-2 cell lysates after PDT with HYP at 16 h
and 24 h incubation are shown in Figure 2. No significant
differences were observed among the control, DMSO, and
dark control groups. According to the results, percentage
of survivin decreased in a dose- and incubation-time–
dependent manner in both HT-29 and Caco-2 cells. In
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A

24h

16h

100

#

80
Survivin %

Control

Figure 1. The amount of total protein (µg/mL) after
photoactivation of HYP for 16 h and 24 h in A) HT-29 and B)
Caco-2. Data is expressed as mean ± SE from three independent
experiments performed in triplicate. Significantly different from
#
: control group, *: 0.04 µM HYP group, **: 0.08 µM HYP group.

60

HT - 29 cells

#

#,*

40
20
0
120

#,*
Control
B

#,*,**

#,*

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP
Caco - 2 cells

100
80
Survivin %

0

60

#,*

#,*
#,* #,*,**

40
20
0

Control

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP

Figure 2. The percentage of survivin after photoactivation of
HYP for 16 h and 24 h in A) HT-29 and B) Caco-2 cells. Data
is expressed as mean ± SE from three independent experiments
performed in triplicate. Significantly different from #: control
group, *: 0.04 µM HYP group, **: 0.08 µM HYP group.
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24h

*

1.2
1
0.8
#

0.6

#.*
#.*.**

0.4
0.2
0

Control

2.5
Relative survivin expression

16h

2

B

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP
Caco -2 cells

#

1.5
1
0.5
0

Control

(Hostanska et al., 2003). Poly (ADP-ribose) polymerase
(PARP) fragmentation, which is an indication of activation
of the effector caspase-3, was the most important step
during HYP-mediated cell death in cervical HeLa cells
(Assefa et al., 1999). PARP cleavage was also observed
in our study, in both HT-29 and Caco-2 cells, after HYP
photoactivation (data not shown). It was reported that
HYP caused increased caspase-9 and caspase-3 activity in
leukemia U937 cells (Hostanska et al., 2003). Similarly, our
observations suggest that caspase-9 activates caspase-3 and
initiates apoptotic cell death in HT-29 and Caco-2 cells.
According to these results, relative gene expression
of caspase-3 was downregulated after 16 h incubation
and upregulated after 24 h incubation, especially in the
0.04 and 0.08 µM HYP groups in HT-29 cells. They were
statistically significant, and the results were compatible
with each other (Figure 4A). The apparent increase in
caspase-3 and caspase-9 gene expressions in 0.08 µM
HYP group indicated induced apoptotic cell death, while
the decrease in expression of these genes likely pointed to
necrotic cell death due to increased HYP concentration. In
Caco-2 cells, upregulation of the caspase-9 gene relative

HT- 29 cells

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP

Figure 3. Relative expression ratio of survivin in A) HT-29 and
B) Caco-2 cells determined by real-time reverse transcription
PCR. Data is expressed as mean ± SE from three independent
experiments performed in triplicate. Significantly different from
#: control group, *: 0.04 µM HYP group, **: 0.08 µM HYP group.

survivin expression was apparent in HT-29 cells for both
16 h and 24 h incubation, while in Caco-2 cells survivin
expression started to increase after 24 h incubation.
However, only the increase in the 0.15 µM HYP group
was statistically significant compared to the control after
24 h incubation (Figure 3B). The decrease in survivin
expression was apparent in HT-29 cells for both 16 h and
24 h incubation, while in Caco-2 cells survivin expression
started to increase after 24 h incubation. This elevation in
Caco-2 cells was in concordance with previous results in
which we found that the apoptotic index decreased after
HYP photoactivation in Caco-2 cells after 24 h incubation.
Interestingly, the apoptotic index decreased suddenly in
the 0.08 µM HYP group in HT-29 cells, which may be due
to the fact that the cells started to resist apoptosis and tried
to survive.
Caspases have been found as inactive proenzymes in
the cell. Whenever the cell receives an apoptosis signal,
procaspases become activated. The caspase family has 14
members in mammals, including caspases -2, -8, -9, and
-10 as initiators and caspases -3, -6, and -7 as executioners

1.4
Relative caspase -3 expression

Relative survivin expression

1.4

HT- 29 cells
A

1.2

A

16h

1

24h

#.*
**

#.*

0.8

#.**

#

0.6
0.4
0.2
0

Relative caspase -3 expression

1.6

1.6
1.4

Control

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP
Caco-2 cells

B
#

1.2

#.*

#.*
#

1
0.8
0.6
0.4
0.2
0

Control

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP

Figure 4. Relative expression ratio of caspase-3 in A) HT-29
and B) Caco-2 cells determined by q-PCR. Data is expressed as
mean ± SE from three independent experiments performed in
triplicate. Significantly different from #: control group, *: 0.04 µM
HYP group, **: 0.08 µM HYP group.
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expression was parallel to the increase in caspase-3
expression, depending on the HYP concentration after
16 h and 24 h incubation. In the 0.15 µM HYP group
the increase was statistically significant compared to the
control group after 16 h and 24 h incubation, and the 0.08
µM HYP group was different from the control and 0.04 µM
HYP groups after 24 h incubation (Figure 4B). Caspase-9
expression was downregulated after 16 h incubation and
upregulated after 24 h incubation in HT-29 cells (Figure
5A). Additionally, a statistically significant increase in
caspase-9 expression was observed in the 0.15 µM HYP
group compared to the control and 0.04 µM HYP groups
after 16 h in Caco-2 cells (Figure 5B).
Induced cell-death type can be influenced by the
genetic basis of a tumor cell. For example, due to the
overexpression of anti-apoptotic Bcl-2 protein, which is
expressed in more than half of all cancer types, resistance
may have occurred after HYP-mediated PDT treatment,
and balance may tend toward necrotic cell death (Reed,
1998). Therefore, decreasing the expression of Bcl-2 is
a way to increase the activity and sensitivity of PDT in
particular cell lines (Fadeel et al., 1999). In a previous study,

HT -29 cells
16h

1.6

#

A

1.4
1.2

**

1
0.8

#.*.**

0.6
0.4
0.2
0

Control

2
Relative caspase -9 expression

24h

B

#.*

1.4
1.2
1
0.8
0.6
0.4
0.2
0

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP

16h

24h

Caco -2 cells

1
#

0.8

#

0.6

#.*.**

0.4
0.2
0

Control

Figure 5. Relative expression ratio of caspase-9 in A) HT-29
and B) Caco-2 cells determined by q-PCR. Data is expressed as
mean ± SE from three independent experiments performed in
triplicate. Significantly different from #: control group, *: 0.04 µM
HYP group, **: 0.08 µM HYP group.
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1.2

Caco-2 cells

1.8
1.6

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP

Relative Bcl-2 expression

Relative caspase -9 expression

2
1.8

it was revealed that HT-29 cells with no Bcl-2 expression
increased anti-apoptotic protein Bcl-XL expression after
HYP-mediated PDT (Mikes et al., 2007). Our findings also
support the results showing HT-29 cells do not express
Bcl-2 gene. On the other hand, Bcl-2 expression increased
in Caco-2 cells when they were confluent under in vitro
conditions (Gauthier et al., 2001). Similarly, we observed
Bcl-2 expression in Caco-2 cells. To our knowledge, this
is the first study showing the HYP-mediated PDT affected
the Bcl-2 expression in Caco-2 cells. The downregulation
of Bcl-2 expression was statistically significant in the 0.04
and 0.08 µM HYP groups, compared to the control, for
24 h incubation after HYP phototactivation. In addition,
the decrease was important in the 0.15 µM HYP group,
compared to all other groups, for 16 h incubation time
(Figure 6).
In colon cancer cells, the ratios of anti-apoptotic protein
Bcl-2 and proapoptotic proteins (Bak and Bax) dominate
the apoptotic potential of a cell. Bcl-2 upregulation is
related to the worst prognosis in colorectal tumorigenesis,
while Bax expression tumors have a better prognosis
(Cerda et al., 2006). Suppressed Bcl-2 and induced Bax
expression are associated with altered apoptotic profiles
in Caco-2 cells (Cerda et al., 2006). Therefore, decreasing
Bcl-2 and increasing Bax, could be a significant target in
PDT in order to increase survival rates for colon cancer.
According to our results, in HT-29 cells downregulation
of Bax expression was statistically significant in the 0.04, 0.08,
and 0.15 µM HYP groups, compared to the control group,
after 24 h incubation. In addition, the upregulation of Bax
expression in the 0.04 µM HYP group after 16 h incubation
was not statistically significant (Figure 7A). Caco-2 cells
responded differently to PDT; Bcl-2 expression decreased
while Bax expression increased, especially in the 0.15 µM
HYP group for 16 h and 24 h incubation time (Figure 7B).

Control

0.04 µM HYP 0.08 µM HYP 0.15 µM HYP

Figure 6. Relative expression ratio of bcl-2 in Caco-2 cells
determined by q-PCR. Data is expressed as mean ± SE from three
independent experiments performed in triplicate. Significantly
different from #: control group, *: 0.04 µM HYP group, **: 0.08
µM HYP group.
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Relative bax expression
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0
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0.04 µM HYP 0.08 µM HYP 0.15 µM HYP

Figure 7. Relative expression ratio of Bax in A) HT-29 and B)
Caco-2 cells determined by q-PCR. Data is expressed as mean ±
SE from three independent experiments performed in triplicate.
Significantly different from #: control group, *: 0.04 µM HYP
group, **: 0.08 µM HYP group.

In conclusion, observed gene expression alterations
related to apoptosis in HT-29 and Caco-2 cells may result
in different responses to HYP-mediated PDT, development
of resistance, or activation of repair mechanisms.
Additionally, these changes may help to determine the
type and time of cell death. We observed for the first time
the different actions of Caco-2 cells faced with HYPmediated PDT in apoptotic pathways. Up- and downregulations of anti-apoptotic survivin gene expressions are
comparable with each other after HYP photoactivation,
as expected. As a limitation of this study, it is difficult
to say that survivin and other apoptosis-associated gene
expressions are directly related to each other after HYP
photoactivation. The alterations in response to HYP
activation in two colon cancer cell lines may be due to
cells that have developed resistance to apoptosis and their
tendency towards necrotic cell-death or the activation of
caspase-independent mechanisms. Further investigations
are essential to shed light on the details of cell-death
mechanisms induced by HYP photoactivation.
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